|
Brief Reports
Citations 121-130 of 1234 total displayed.
|
Past content
(since Jul 1999):
|
Activity of the BH3 mimetic ABT-737 on polycythemia vera erythroid precursor cells
- Ann Zeuner, Francesca Pedini, Federica Francescangeli, Michele Signore, Gabriella Girelli, Agostino Tafuri, and Ruggero De Maria
Blood 2009; 113: 1522-1525.
[Abstract]
[Full text]
[PDF]
Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13
- Todd A. Fehniger, John C. Byrd, Guido Marcucci, Camille N. Abboud, Cheryl Kefauver, Jacqueline E. Payton, Ravi Vij, and William Blum
Blood 2009; 113: 1002-1005.
[Abstract]
[Full text]
[PDF]
Gene expression profiling of peripheral T-cell lymphoma including  T-cell lymphoma
- Kana Miyazaki, Motoko Yamaguchi, Hiroshi Imai, Tohru Kobayashi, Satoshi Tamaru, Kazuhiro Nishii, Masao Yuda, Hiroshi Shiku, and Naoyuki Katayama
Blood 2009; 113: 1071-1074.
[Abstract]
[Full text]
[PDF]
Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group–directed intergroup trial S9003
- Madhav V. Dhodapkar, Antje Hoering, Morie A. Gertz, Saul Rivkin, Jackie Szymonifka, John Crowley, and Bart Barlogie
Blood 2009; 113: 793-796.
[Abstract]
[Full text]
[PDF]
RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis
- Ming Yan, Eun-Young Ahn, Scott W. Hiebert, and Dong-Er Zhang
Blood 2009; 113: 883-886.
[Abstract]
[Full text]
[PDF]
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab
- Farrukh T. Awan, Neil E. Kay, Melanie E. Davis, Wenting Wu, Susan M. Geyer, Nelson Leung, Diane F. Jelinek, Renee C. Tschumper, Charla R. Secreto, Thomas S. Lin, Michael R. Grever, Tait D. Shanafelt, Clive S. Zent, Timothy G. Call, Nyla A. Heerema, Gerard Lozanski, John C. Byrd, and David M. Lucas
Blood 2009; 113: 535-537.
[Abstract]
[Full text]
[PDF]
Both primitive and definitive blood cells are derived from Flk-1+ mesoderm
- Jesse J. Lugus, Changwon Park, Yunglin D. Ma, and Kyunghee Choi
Blood 2009; 113: 563-566.
[Abstract]
[Full text]
[PDF]
Impaired negative regulation of homeostatically proliferating T cells
- Anna Shvets, Rabindranath Chakrabarti, Rosana Gonzalez-Quintial, Roberto Baccala, Argyrios N. Theofilopoulos, and Gérald J. Prud'homme
Blood 2009; 113: 622-625.
[Abstract]
[Full text]
[PDF]
Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia
- Lyndal Kearney, David Gonzalez De Castro, Jenny Yeung, Julia Procter, Sharon W. Horsley, Minenori Eguchi-Ishimae, Caroline M. Bateman, Kristina Anderson, Tracy Chaplin, Bryan D. Young, Christine J. Harrison, Helena Kempski, Chi Wai E. So, Anthony M. Ford, and Mel Greaves
Blood 2009; 113: 646-648.
[Abstract]
[Full text]
[PDF]
In vivo expansion of cells expressing acquired CSF3R mutations in patients with severe congenital neutropenia
- Manuela Germeshausen, Karl Welte, and Matthias Ballmaier
Blood 2009; 113: 668-670.
[Abstract]
[Full text]
[PDF]
|
|